Author:
Gabitzsch E S,Xu Y,Balcaitis S,Balint J P,Jones F R
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference40 articles.
1. Higano CS, Schellhammer PF, Small EJ, Burch PA, Nemunaitis J, Yuh L et al. Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer. Cancer 2009; 115: 3670–3679.
2. Romano G, Pacilio C, Giordano A . Gene transfer technology in therapy: current applications and future goals. Stem Cells 1999; 17: 191–202.
3. Kirk CJ, Hartigan-O’Connor D, Mule JJ . The dynamics of the T-cell anitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally. Cancer Res 2001; 61: 8794–8802.
4. Kirk CJ, Hartigan-O’Connor D, Nickoloff BJ, Chamberlain JS, Giedlin M, Aukerman L et al. T cell-dependant antitumor immunity mediated by secondary lympoid tissue chemokine: augmentation of dendrtitic cell-based immunotherapy. Cancer Res 2001; 61: 2062–2070.
5. Polo JM, Dubensky Jr TW . Virus-based vectors for human vaccine applications. Drug Discov Today 2002; 7: 719–727.